Penny Stock Wallbusters

[million]

Is that one like this one at IMDS:


Imaging Diagnostic Systems Installs Its CT Laser Mammography System in Mumbai, India


2010-07-12 10:34 ET - News Release


FORT LAUDERDALE, Fla. -- (Business Wire)

Imaging Diagnostic Systems, Inc., (IDSI) (OTCBB: IMDS) a pioneer in laser optical breast imaging, announced today that it has installed the first CT Laser Mammography (CTLM) system at Tata Memorial Hospital, the national comprehensive cancer centre in Mumbai, India.

Tata Memorial is participating in the marketing campaign and consumer awareness program created by IDSI’s local distributor Anto Puthiry, the Managing Director of High-Tech Healthcare Equipments Pvt. Ltd. The hospital will introduce the CTLM system and its ability to detect breast cancer for the women in the region. Industry leaders in radiology, as well as patients, will be invited to the hospital to view the CTLM system and receive an introduction to CTLM technology and its images.

Earlier this year, Dr. Muhammad Emad, of Saqr Hospital, Ras al-Khaimah, United Arab Emirates (UAE) gave a presentation to Tata Memorial Hospital on behalf of the CTLM system. As one of the first physicians to work with the CTLM system, he is regarded as the pioneer in the implementation of CTLM as part of his breast cancer management plan. Dr. Emad’s presentation focused on his personal research and the capable performance of the CTLM system in detecting breast cancer among his patients.

“We are very pleased with the installation at Tata Memorial Hospital, and with their collaboration on the marketing campaign,” stated Mr. Puthiry. “It is very gratifying that India’s national comprehensive cancer center is working with the system and with our team to introduce leaders in radiology and patients to CTLM technology.”

Tata Memorial was founded in 1941 and is located in Mumbai, Maharashtra, India. The hospital is recognized as the leading comprehensive cancer institute for all of India for prevention, treatment, education, and research on breast cancer.

About Imaging Diagnostic Systems, Inc.

Imaging Diagnostic Systems, Inc. has developed a revolutionary new imaging device to aid in the detection and management of breast cancer. The CTLM system is a breast imaging system that utilizes patented continuous wave laser technology and computer algorithms to create 3-D images of the breast. The procedure is non-invasive, painless, and does not expose the patient to ionizing radiation or painful breast compression. CTLM is designed to be used in conjunction with mammography. It reveals information about blood distribution in the breast and may visualize the process of angiogenesis, which usually accompanies tumor growth.

Imaging Diagnostic Systems is undergoing the clinical studies for the future filing of the Food and Drug Administration (FDA) marketing clearance for its Computed Tomography Laser Mammography (CTLM) system to be used as an adjunct to mammography. The FDA has determined that the Company's clinical study is a non-significant risk (NSR) investigational device study under 812.3(m) of the investigational device exemptions (IDE) regulation (21 CFR 812). The CTLM system is limited by United States Federal Law to investigational use only in the United States. The CTLM system has received other registrations including CE, CMDCAS Canadian License, China SFDA, UL, ISO 9001:2000, ISO 13485:2003 and FDA export certification.

For more information, visit our website: http://www.imds.com.

As contemplated by the provisions of the Safe Harbor section of the Private Securities Litigation Reform Act of 1995, this news release may contain forward-looking statements pertaining to future, anticipated, or projected plans, performances and developments, as well as other statements relating to future operations. All such forward-looking statements are necessarily only estimates or predictions of future results or events and there can be no assurance that actual results or events will not materially differ from expectations. Further information on potential factors that could affect Imaging Diagnostic Systems, Inc., is included in the Company's filings with the Securities and Exchange Commission. We expressly disclaim any intent or obligation to update any forward-looking statements.



Contacts:

Imaging Diagnostic Systems, Inc.
Deborah O’Brien, 954-257-8940


Source: Imaging Diagnostic Systems, Inc.